Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility

Surgery Partners, Inc., a small-cap player in the hospital industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at $21.62, down from a previous close of $22.03. Over the past year, the stock has experienced significant volatility, with a 52-week high of $33.37 and a low of $18.87.
The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bullish trend on a weekly basis, while the monthly perspective leans bearish. The Relative Strength Index (RSI) presents no clear signals for both weekly and monthly evaluations. Bollinger Bands suggest a sideways movement weekly, but a bearish stance monthly. Daily moving averages indicate a bearish trend, and the On-Balance Volume (OBV) reflects bearish sentiment in both weekly and monthly assessments.

In terms of returns, Surgery Partners has faced challenges compared to the S&P 500. Over the past week, the stock returned -1.14%, while the S&P 500 gained 1.22%. In the one-month period, the stock's return was -6.81%, contrasting with the S&P 500's 3.95%. Year-to-date, Surgery Partners has managed a modest gain of 2.13%, but this pales in comparison to the S&P 500's 13.31% return. Over longer periods, the disparity becomes more pronounced, with the stock down 34.74% over the past year and 20.81% over three years, while the S&P 500 has shown positive growth. These trends highlight the challenges Surgery Partners faces in a competitive market landscape.